Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113247 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yi Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Henan University of Chinese Medicine, Zhengzhou 450046 China; Henan Engineering Research Center for Chinese Medicine Foods for Speci…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Esophageal Squamous Cell Carcinoma, Signal Transduction, Thyroid Hormone-Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Pterostilbene (PTS) is a dietary phytochemical that has shown antitumor activity in many types of cancer, but the molecular mechanism remains unclear. It has also not been adequately studied on PTS against esophageal squamous cell carcinoma (ESCC). Thus, this study investigated the effect of PTS on ESCC in vitro and in vivo and explored the underlying molecular mechanism. We found that PTS can inhibit the proliferation, colony formation, and migration of ESCC cells. According to the bioinformatics analysis of proteomics, PTS had a great influence on the metabolic process of ESCC cells. KEGG analysis showed that PTS down-regulated the pyruvate metabolism pathway. Moreover, PTS can inhibit the PK activity, glucose consumption, and lactate production in ESCC cells. By administration of PTS into xenograft mice, experiment results demonstrated that PTS can suppress tumor progress and the PKM2/STAT3/c-MYC signaling pathway. We found that PTS inhibited the PKM2/STAT3/c-MYC signaling pathway by targeting PKM2 in ESCC cells. Collectively, this study revealed that PTS inhibited ESCC growth by suppressing PKM2 mediated aerobic glycolysis and PKM2/STAT3/c-MYC signaling pathway, which enriching the anti-tumor molecular mechanism of PTS and providing a theoretical basis for its clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College, Henan University of Chinese Medicine, Zhengzhou 450046 China; Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou 450046 China.
- The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450046 China.
- Henan Key Laboratory of Chronic Disease Management, Fuwai Central China Cardiovascular Hospital, Zhengzhou 450018 China.
- Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou 450046 China; The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450046 China. Electr…
- Medical College, Henan University of Chinese Medicine, Zhengzhou 450046 China; Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou 450046 China. Electronic address: fsy@ha…
Zitieren
APA
Yang, Y., Li, S., Shi, W., Jin, G., Guo, D., Li, A., Wang, B., Lu, B., & Feng, S. (2024). Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113247
Vancouver
Yang Y, Li S, Shi W, Jin G, Guo D, Li A, et al. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113247
BibTeX
@article{Yang2024,
author = {Yang, Yi and Li, Shan and Shi, Wenjie and Jin, Guoguo and Guo, Dandan and Li, Aifang and Wang, Baiyan and Lu, Baoping and Feng, Shuying},
title = {Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113247}
}
EUVIMED